EOM 1352: Fri 7 June 2024, 11:36

Current Edition

ramusmedical
Under Surveillance: How Risk-based Monitoring Improves the Success and Efficiency of Clinical Trials
Editorial Archive

Under Surveillance: How Risk-based Monitoring Improves the Success and Efficiency of Clinical Trials

The biopharmaceutical industry, reeling under the pressures of low R&D productivity and increased costs of clinical development, has been looking at ways to do mo...
Continue Reading →
Evolution of the Trial Master File Process
Editorial Archive

Evolution of the Trial Master File Process

There are a number of challenges facing the pharmaceutical industry, such as improving the quality of TMF documentation through a compliant centralised filing system....
Continue Reading →
Cardiovascular Therapeutics Watch Page
Editorial Archive

Cardiovascular Therapeutics Watch Page

Drug-resistant hypertension (RHTN) is a 'hot topic' in hypertension literature. Uncontrolled RHTN is defined as blood pressure (BP) above goal on an appropriate pharm...
Continue Reading →
Aortic Stiffness and Chronic Obstructive Pulmonary Disease
Editorial Archive

Aortic Stiffness and Chronic Obstructive Pulmonary Disease

Arterial stiffness, especially stiffness in the large elastic arteries such as the aorta, is now widely-recognised as an important factor in the development and progr...
Continue Reading →
Our Love/Hate Relationship with Clinical Surveillance, and Why Both are Valid
Editorial Archive

Our Love/Hate Relationship with Clinical Surveillance, and Why Both are Valid

CNS researchers have implemented surveillance strategies from within pharmaceutical companies, through contract research organizations, or by using one of the many in...
Continue Reading →
An Overview of the Legislative Framework for FDA Expedited Programs for Serious Conditions
Editorial Archive

An Overview of the Legislative Framework for FDA Expedited Programs for Serious Conditions

On June 26, 2013, the US Food and Drug Administration (FDA) announced in the Federal Register, the publication of a draft guidance for industry entitled “Expedited Pr...
Continue Reading →
Quotient